sorafenib has been researched along with dapagliflozin in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (dapagliflozin) | Trials (dapagliflozin) | Recent Studies (post-2010) (dapagliflozin) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 1,478 | 368 | 1,407 |
Protein | Taxonomy | sorafenib (IC50) | dapagliflozin (IC50) |
---|---|---|---|
Sodium/glucose cotransporter 1 | Homo sapiens (human) | 1.1661 | |
Sodium/glucose cotransporter 2 | Homo sapiens (human) | 0.0022 | |
Sodium/myo-inositol cotransporter 2 | Homo sapiens (human) | 0.38 | |
Solute carrier family 5 member 4 | Homo sapiens (human) | 0.0014 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cui, Y; Dong, Z; Fu, Y; He, X; Li, Y; Ma, Y; Xun, X | 1 |
1 other study(ies) available for sorafenib and dapagliflozin
Article | Year |
---|---|
Development of UPLC-MS/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats.
Topics: Acetonitriles; Animals; Benzhydryl Compounds; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Chromatography, Liquid; Diabetes Mellitus, Type 2; Glucose; Glucosides; Glucuronosyltransferase; Liver Neoplasms; Rats; Reproducibility of Results; RNA, Messenger; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Sorafenib; Tandem Mass Spectrometry; Uridine Diphosphate | 2022 |